Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,46 USD | -2,50% | -2,67% | -46,10% |
Omzet 2024 * | 34,3 mln. 32,02 mln. | Omzet 2025 * | 24,82 mln. 23,18 mln. | Marktkapitalisatie | 449 mln. 419 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -206 mln. -192 mln. | Nettowinst (verlies) 2025 * | -242 mln. -226 mln. | EV/omzet 2024 * | 5,73 x |
Nettoliquiditeiten 2024 * | 252 mln. 236 mln. | Nettoliquiditeiten 2025 * | 95 mln. 88,7 mln. | EV/omzet 2025 * | 14,3 x |
K/w-verhouding 2024 * |
-2,28
x | K/w-verhouding 2025 * |
-2,19
x | Werknemers | 265 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,68% |
Recentste transcriptie over Editas Medicine, Inc.
1 dag | -2,50% | ||
1 week | -2,67% | ||
Lopende maand | -26,42% | ||
1 maand | -25,82% | ||
3 maanden | -32,09% | ||
6 maanden | -16,89% | ||
Lopend jaar | -46,10% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01-06-22 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 17-05-23 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 24-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 03-09-21 |
David Scadden
BRD | Director/Board Member | 71 | 06-02-19 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 28-07-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
4.83% | 2 M€ | -25,75% | ||
0.13% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0,00% | - | |
0.06% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 5,6 | +2,00% | 1 745 138 |
19-04-24 | 5,49 | -1,08% | 2 264 535 |
18-04-24 | 5,55 | -1,07% | 1 715 551 |
17-04-24 | 5,61 | -4,10% | 1 910 234 |
16-04-24 | 5,85 | -3,78% | 1 338 818 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,10% | 461 mln. | |
+3,13% | 42,11 mld. | |
+48,83% | 40,08 mld. | |
+8,49% | 40 mld. | |
-10,82% | 26,87 mld. | |
+8,26% | 24,58 mld. | |
-23,69% | 18,44 mld. | |
+1,58% | 11,94 mld. | |
+32,83% | 11,66 mld. | |
+6,63% | 11,01 mld. |